NCT05618535

Brief Summary

The aim of this study was to determine the differences in hemodynamics between different positions in patients undergoing ultra-early reperfusion therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 16, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

March 1, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

November 10, 2022

Last Update Submit

February 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Differences in blood pressure variability(BPV)between different positions

    BPV is defined as blood pressure oscillations in relation to the mean values.

    0-7 days

  • Differences in heart rate variability (HRV) between different positions

    HRV is defined as heart rate oscillations in relation to the mean values.

    0-7 days

Secondary Outcomes (1)

  • The difference of middle cerebral artery blood flow velocity between different positions.

    0-7 days

Study Arms (2)

Zero position

SHAM COMPARATOR

All monitoring was done from 9 to 11 a.m., and the whole monitoring process was carried out in a specific and quiet environment at 20-24℃ to avoid other auditory and visual stimuli. After 10min of the relaxed supine position, the blood pressure, heart rate, and blood flow velocity of the middle cerebral artery were measured in the 0° position for 5min.

Device: Transcranial Doppler.

30 degrees position

EXPERIMENTAL

Within 30 seconds after the 0° position measurement completion, the subjects were transferred to the 30° position and rested for 15 minutes under the 30° position. In other words, a washout period of 15 minutes was established between two measurements to ensure the stability of vital signs and avoid confounding effects. The blood pressure, heart rate, and blood flow velocity of the middle cerebral artery were measured again for 5 minutes after the vital signs were stable.

Device: Transcranial Doppler.

Interventions

Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler.

30 degrees positionZero position

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥18 years, \< 80 years, regardless of sex;
  • Patients with clinically confirmed acute ischemic stroke who received intravenous thrombolysis or emergency endovascular treatment;
  • Baseline National Institute of Health stroke scale(NIHSS)score ≤25;
  • Baseline Glasgow Coma Scale (GCS) ≥8;
  • Signed and dated informed consent is obtained

You may not qualify if:

  • The patient has clear indications or contraindications, such as active vomiting, spinal cord injury;
  • Clinicians considered that the assigned body position could not be maintained; Patients unable to cooperate with all noninvasive beat-by-beat continuous BP monitoring;
  • Poor temporal window penetration;
  • Patients with diseases that seriously affect hemodynamics, such as atrial fibrillation, anemia, and hyperthyroidism;
  • Previous history of atrial fibrillation or ECG showing atrial fibrillation or arrhythmia;
  • Pregnant or lactating women;
  • Poor treatment compliance;
  • Complicated with severe systemic diseases, such as heart failure, respiratory failure, renal failure, gastrointestinal bleeding, coagulopathy, malignant tumors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Hospital of Jilin University

Changchun, Jilin, China

Location

MeSH Terms

Conditions

Ischemic Stroke

Interventions

Ultrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associated Dean of The First Hospital of Jilin University

Study Record Dates

First Submitted

November 10, 2022

First Posted

November 16, 2022

Study Start

December 1, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

March 1, 2024

Record last verified: 2024-02

Locations